Cite
MLA Citation
Francis Berenbaum et al.. “LB0007 SUBCUTANEOUS TANEZUMAB FOR OSTEOARTHRITIS PAIN: A 24-WEEK PHASE 3 STUDY WITH A 24-WEEK FOLLOW UP.” Annals of the rheumatic diseases, vol. 78, n.d., pp. 262–264. http://access.bl.uk/ark:/81055/vdc_100144725564.0x000057